Abstract
Increased de novo lipogenesis and reduced fatty acid oxidation are probable contributors to adipose accretion in obesity. Moreover, these perturbations have a role in leading to non-alcoholic steatohepatitis, dyslipidemia, and insulin resistance—via “lipotoxicity”-related mechanisms. Research in this area has prompted an effort to evaluated several discrete enzymes in these pathways as targets for future therapeutic intervention. Acetyl-CoA carboxylase 1 (ACC1) and ACC2 regulate fatty acid synthesis and indirectly control fatty acid oxidation via a key product, malonyl CoA. Based on mouse genetic and preclinical pharmacologic evidence, inhibition of ACC1 and/or ACC2 may be a useful approach to treat obesity and metabolic syndrome. Similarly, available data suggest that inhibition of other enzymes in this pathway, including fatty acid synthase, stearoyl CoA desaturase, and diacylglycerol acytransferase 1, will have beneficial effects. AMP-activated protein kinase is a master regulator of nutrient metabolism, which controls several aspects of lipid metabolism. Activation of AMPK in selected tissues is also a potential therapeutic approach. Inhibition of hormonesensitive lipase is another possible approach. The rationale for modulating the activity of these enzymes and their relative merits (and downsides) as possible therapeutic targets are further discussed.
Similar content being viewed by others
References
Moller, D. E. and Kaufman K. D. (2005). Ann. Rev. Med. 56, 45–62.
Lam, T. K. T., Schwartz, G. J., and Rossetti, L. (2005). Nature Neurosci. 8, 579–584.
Donnelly, K., Smith, C., Schwarzenberg, S., et al. (2005). J. clin. Invest. 115, 1343–1351.
Marques-Lopez, I., Ansorena, D., Astiasaran, I., et al. (2001). Am. J. Clin. Nutrition 73, 253–261.
Lowell, B. and Spiegelman, B. (2000). Nature 404, 652–660.
Bogardus, C., Lillioja, S., Ravussin, E., et al. (1986). N. Engl. J. Med. 315, 96–100.
Ravussin, E. and Swinburn, B. (1996). Diabetes Rev. 4, 403–422.
Howard, B. and Howard, W. 1994). Endocrine Rev. 15, 263–274.
Unger, R. (1995). Diabetes 44, 863–870.
Berger, J. and Moller, D. E. (2002). Ann. Rey. Med. 53, 409–435.
Zhou, G., Myers, R., Li, Y., et al. (2001). J. Clin. Invest. 108, 1167–1174.
Abu-Elheiga, L., Brinkley, W. R., Zhong, L., et al. (2000). Proc. Natl. Acad. Sci. USA 97, 1444–1449.
Bianchi, A., Evans, J. L., Iverson, A. J., et al. (1990). J. Biol. Chem. 265, 1502–1509.
Kim, K. H. (1997). Annu. Rev. Nutr. 17, 77–99.
Abu-Elheiga, L., Matzuk, M. M., Kordari, P., et al. (2005). Proc. Natl. Acad. Sci. USA 102, 12011–12016.
Winder, W. W., MacLean, P. S., Lucas, J. C., et al. (1995). J. Appl. Physiol. 78, 578–582.
Vavvas, D., Apazidis, A., Saha, A. K., et al. (1997). J. Biol. Chem. 272, 13255–13261.
Abu-Elheiga, L., Almarza-Ortega, D. B., Baldini, A., and Wakil, S. J. (1997). J. Biol. Chem. 272, 10669–10677.
Abu-Elheija, L., Matzuk, M., Abo-Hasema, K., and Wakil, S. (2001). Science 291, 2613–2616.
Abu-Elheiga, L., Oh, W., Kordari, P., and Wakil, S. J. (2003). Proc. Natl. Acad. Sci. USA 100, 10207–10212.
Oh, W., Abu-Elheiga, L., Kordari, P., et al. (2005). Proc. Natl. Acad. Sci. USA 102, 1384–1389.
McCune, S. A. and Harris R. A. (1979). J. Biol. Chem. 254, 10095–10101.
Arbeeny, C. M., Meyers, D. S., Bergquist, K. E., and Gregg, R. E. (1992). J. Lipid Res. 33, 843–851.
Fukuda, N. and Ontko, J. A. (1984). J. Lipid Res. 25, 831–842.
Parker, R. A., Kariya, T., Grisar, J. M., and Petrow, V. (1977). J. Med. Chem. 20, 781–791.
Rose-Kahn, G. and Bar-Tana, J. (1990). Biochim. Biophys. Acta 1042, 259–264.
Tzur, R., Rose-Kahn, G., Adler, J. H., and Bar-Tana, J. (1988). Diabetes 37, 1618–1624.
Groot, P. H., Pearce, N. J., and Gribble, A. D. (2003). Curr. Med. Chem.-Immun. Endoc. Metab. Agents 3, 211–217.
Harwood, H. J. Jr., Petras, S. F., Shelly, L. D., et al. (2003). J. Biol. Chem. 278, 37099–37111.
Harwood, H. J. Jr. (2005) Expert Opin. Ther. Targets 9, 267–281.
Wakil, S. J. (1989). Biochemistry 28, 4523–4530.
Ruderman, N. B., Saha, A. K., Vavas, D., and Witters, L. A. (1999). Am. J. Physiol. 276, E1-E18.
Chirala, S. S., Chang, H., Matzuk, M., et al. (2003). Proc. Natl. Acad. Sci. USA 100, 6358–6363.
Pan, D. A., Lillioja, S., Kriketos, A. D., et al. (1997). Diabetes 46, 983–988.
Loftus, T. M., Jaworsky, D. E., Frehywot, G. L., et al. (2000). Science 288, 2379–2381.
Shimokawa, T., Kumar, M. V., and Lane, M. D. (2002). Proc. Natl. Acad. Sci. USA 99, 66–71.
Thupari, J. N., Landree, L. E., Ronnett, G. V., and Kuhajda, F. P. (2002). Proc. Natl. Acad. Sci. USA 99, 9498–9502.
Hardie, D., Carling, D., and Carlson, M. (1998). Ann. Rev. Biochem. 67, 821–855.
Winder, W. and Hardie, D. (1999). Am. J. Physiol. 40, E1-E10.
Minokoshi, Y., Kim, T-B., Peroni, O., et al. (2002). Nature 415, 339–343.
Yamauchi, T., Kamon, J., Ito, Y., et al. (2003). Nature 423, 762–769.
Ruderman, N., Saha, A., and Kraegen, E. (2003). Endocrinology 144, 5166–5171.
Winder, W., Holmes, B., Rubink, D., et al. (2000). J. Appl. Physiol. 88, 2219–2226.
Minokoshi, Y., Alqular, T., Furukawa, N., et al. (2004). Nature 428, 569–574.
Andersson, U., Filipsson, K., Abbott, C., et al. (2004). J. Biol. Chem. 279, 12005–12008.
Enoch, H. G. and Strittmatter, P. (1978). Biochemistry 17, 4927–4932.
Wang, J., Yu, L., Schmidt, R. E., et al. (2005). Biochem. Biophys. Res. Commun. 332, 735–742.
Ntambi, J. M. and Miyazaki, M. (2003). Curr. Opin. Lipidol. 14, 255–261.
Miyazaki, M., Jacobson, M. J., Man, W. C., et al. (2003). J. Biol. Chem. 278, 33904–33911.
Miyazaki, M., Kim, Y. C., Gray-Keller, M. P., et al. (2000). J. Biol. Chem. 275, 30132–30138.
Miyazaki, M., Kim, Y. C., and Ntambi, J. M. (2001). J. Lipid Res. 42, 1018–1025.
Cohen, P., Miyazaki, M., Socci, N. D., et al. (2002). Science 297, 240–243.
Miyazaki, M., Man, W. C., and Ntambi, J. M. (2001). J. Nutr. 131, 2260–2268.
Ntambi, J. M., Miyazaki, M., Stoehr, J. P., et al. (2002). Proc. Natl. Acad. Sci. USA 99, 11482–11486.
Dobrzyn, P., Dobrzyn, A., Miyazaki, M., et al. (2004). Proc. Natl. Acad. Sci. USA 101, 6409–6414.
Miyazaki, M., Dobrzyn, A., Sampath, H., et al. (2004). J. Biol. Chem. 279, 35017–35024.
Jiang, G., Li, Z., Liu, F., et al. (2005). J. Clin. Invest. 115, 1030–1038.
Sviridov, S., Kodumuru, V., Liu, S., et al. (2005). Patent No. WO 2005011657.
Fredrikson, G., Stralfors, P., Nilsson, N. O., and Belfrage, P. (1981). Methods Enzymol. 71 (Pt C), 636–646.
Eriksson, H., Ridderstrale, M., Degerman, E., et al. (1995). Biochim. Biophys. Acta 1266, 101–107.
Osuga, J, Ishibashi, S., Oka, T., et al. (2000). Proc. Natl. Acad. Sci. USA 97, 787–792.
Haemmerle, G., Zimmermann, R., Hayn, M., et al. (2002). J. Biol. Chem. 277, 4806–4815.
Haemmerle, G., Zimmermann, R., Strauss, J. G., et al. (2002). J. Biol. Chem. 277, 12946–12952.
Voshol, P. J., Haemmerle, G., Ouwens, D. M., et al. (2003). Endocrinology 144, 3456–3462.
Park, S. Y., Kim, H. J., Wang, S., et al. (2005). Am. J. Physiol. Endocrinol. Metab. 289, E30–39.
Wang, S. P., Laurin, N., Himms-Hagen, J., et al. (2001). Obes. Res. 9, 119–128.
Harada, K., Shen, W. J., Patel, S., et al. (2003). Am. J. Physiol. Endocrinol. Metab. 285, E1182–1195.
Zimmermann, R., Haemmerle, G., Wagner,E. M., et al. (2003). J. Lipid Res. 44, 2089–2099.
Sekiya, M., Osuga, J., Okazaki, H., et al. (2004). J. Biol. Chem. 279, 15084–15090.
Zechner, R., Strauss, J. G., Haemmerle, G., et al. (2005). Curr. Opin. Lipidol. 16, 333–340.
Yu, Y. H. and Ginsberg, H. N. (2004). Ann. Med. 36, 252–261.
Farese, R. V. Jr., Cases, S., and Smith, S. J. (2000). Curr. Opin. Lipidol. 11, 229–234.
Cheng, D., Meegalla, R. L., He, B., et al. (2001). Biochem. J. 359, 707–714.
Cases, S., Smith, S. J., Zheng, Y. W., et al. (1998). Proc. Natl. Acad. Sci. USA 95, 13018–13023.
Smith, S. J., Cases, S., Jensen, D. R., et al. (2000). Nat. Genet. 25, 87–90.
Chen, H. C., Smith, S. J., Ladha, Z., et al. (2002). J. Clin. Invest. 109, 1049–1055.
Chen, H. C., Jensen, D. R., Myers, H. M., et al. (2003). J. Clin. Invest. 111, 1715–1722.
Chen, H. C., Rao, M., Sajan, M. P., et al. (2004). Diabetes 53, 1445–1451.
Chen, H. C., Smith, S. J., Tow, B., et al. (2002). J. Clin. Invest. 109, 175–181.
Yu, X. X., Murray, S. F., Pandey, S. K., et al. (2005). Hepatology 42, 362–371.
Stone, S. J., Myers, H. M., Watkins, S. M., et al. (2004). J. Biol. Chem. 279, 11767–11776.
Pearce, N. J., Yates, J. W., Berkhout, T. A., et al. (1998). Biochem. J. 334 (Pt 1), 113–119.
Beigneux, A. P., Kosinski, C., Gavino, B., et al. (2004). J. Biol. Chem. 279, 9557–9564.
Coleman, R. A., Lewin, T. M., and Muoio, D. M. (2000). Annu. Rev. Nutr. 20, 77–103.
Gonzalez-Baro, M. R., Granger, D. A., and Coleman, R. A. (2001). J. Biol. Chem. 276, 43182–43188.
Muoio, D. M., Seefeld, K., Witters, L. A., and Coleman, R. A. (1999). Biochem. J. 338 (Pt 3), 783–791.
Hammond, L. E., Gallagher, P. A., Wang, S., et al. (2002). Mol. Cell. Biol. 22, 8204–8214.
Neschen, S., Morino, K., Hammond, L. E., et al. (2005). Cell Metab. 2, 55–65.
Lehner, R. and Kuksis, A. (1996). Prog. Lipid Res. 35, 169–201.
Cao, J., Lockwood, J., Burn, P., and Shi, Y. (2003). J. Biol. Chem. 278, 13860–13866.
Cao, J., Hawkins, E., Brozinick, J. et al. (2004). J. Biol. Chem. 279, 18878–18886.
Luan, Y., Hirashima, T., Man, Z. W., et al. (2002). Diabetes Res. Clin. Pract. 57, 75–82.
IDF Worldwide Definition of the Metabolic Syndrome. (1995) www.idf.org.
Cortez-Pinto, H. and Camilo, M. (2004). Best Practice Res. Clin. Gastroenterol. 18, 1089–1104.
Harwood, H. Jr. (2004). Curr. Opin. Invest. Drugs 5, 283–289.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Kusunoki, J., Kanatani, A. & Moller, D.E. Modulation of fatty acid metabolism as a potential approach to the treatment of obesity and the metabolic syndrome. Endocr 29, 91–100 (2006). https://doi.org/10.1385/ENDO:29:1:91
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:29:1:91